# Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

> **NCT00095914** · PHASE1 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** paclitaxel
- **DRUG:** paclitaxel albumin-stabilized nanoparticle formulation

## Key facts

- **NCT ID:** NCT00095914
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-05
- **Final completion:** 2009-03
- **Target enrollment:** — (—)
- **Last updated:** 2012-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00095914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00095914, "Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00095914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*